Company Encyclopedia
View More
name
Scienture
SCNX.US
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products.
64.63 B
SCNX.USMarket value -Rank by Market Cap -/-

Financial Score

13/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking22/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-24.07%E
    • Profit Margin-3145.84%E
    • Gross Margin97.39%A
  • Growth ScoreB
    • Revenue YoY207.88%A
    • Net Profit YoY-550.47%E
    • Total Assets YoY11.21%B
    • Net Assets YoY-2.89%D
  • Cash ScoreB
    • Cash Flow Margin-3.18%D
    • OCF YoY207.88%A
  • Operating ScoreE
    • Turnover0.01E
  • Debt ScoreA
    • Gearing Ratio21.14%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --